Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Deciphera Pharmaceuticals, Inc. (DCPH)  
$25.36 0.01 (0.04%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 60,930,000
Market Cap: 1.55(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $10.11 - $25.38
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. In addition, Co. has identified and developed various product candidates from its platform into clinical studies, including vimseltinib and DCC-3116. Co. is studying vimseltinib in a Phase 3 study in patients with tenosynovial giant cell tumor. DCC-3116 is designed to inhibit autophagy, a key tumor survival mechanism in cancer cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 10,000 1,687,666
Total Buy Value $0 $0 $138,828 $30,291,232
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 1 3
Total Shares Sold 10,159 75,715 115,161 179,650
Total Sell Value $158,659 $1,108,986 $1,602,723 $2,646,007
Total People Sold 4 5 6 6
Total Sell Transactions 4 14 25 43
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 290
  Page 3 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2023-02-16 4 S $15.10 $20,686 D/D (1,370) 58,795 5%     
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2023-02-16 4 S $15.10 $20,686 D/D (1,370) 58,813 5%     
   Pitman Jama See Remarks   •       –      –    2023-02-15 4 A $0.00 $0 D/D 11,151 46,209     -
   Martin Daniel C. Chief Commercial Officer   •       –      –    2023-02-15 4 A $0.00 $0 D/D 11,151 59,540     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2023-02-15 4 A $0.00 $0 D/D 16,488 89,116     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2023-02-15 4 A $0.00 $0 D/D 16,488 60,165     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2023-02-15 4 A $0.00 $0 D/D 16,488 60,183     -
   Hoerter Steven L. President and CEO   •       •      –    2023-02-14 4 AS $16.00 $480,720 D/D (30,045) 7,500 -9%     
   Brightstar Associates Llc 10% Owner   –       –       •   2023-01-24 4 B $18.00 $29,999,988 D/D 1,666,666 19,718,014 2.45 -22%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2023-01-17 4 S $21.24 $51,043 D/D (2,403) 43,677 34%     
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2023-01-17 4 S $21.24 $51,043 D/D (2,403) 43,695 34%     
   Pitman Jama See Remarks   •       –      –    2023-01-17 4 S $21.24 $34,050 D/D (1,603) 35,058 34%     
   Martin Daniel C. Chief Commercial Officer   •       –      –    2023-01-17 4 S $21.24 $34,050 D/D (1,603) 48,389 34%     
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2023-01-17 4 S $21.24 $51,043 D/D (2,403) 72,628 34%     
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2022-10-03 4 S $18.73 $48,455 D/D (2,587) 74,297 13%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2022-06-16 4 S $10.75 $19,006 D/D (1,768) 46,080 -59%     
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2022-06-16 4 S $10.75 $19,006 D/D (1,768) 76,884 -59%     
   Pitman Jama See Remarks   •       –      –    2022-06-16 4 S $10.75 $13,954 D/D (1,298) 36,661 -59%     
   Martin Daniel C. Chief Commercial Officer   •       –      –    2022-06-16 4 S $10.75 $14,093 D/D (1,311) 49,521 -59%     
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2022-06-16 4 S $10.75 $19,006 D/D (1,768) 46,098 -59%     
   Brightstar Associates Llc 10% Owner   –       –       •   2022-04-29 4 B $10.00 $14,789,780 D/D 1,478,978 18,051,348 2.45 79%     
   Hoerter Steven L. President and CEO   •       •      –    2022-03-21 4 D $9.11 $28,697 D/D (3,150) 37,545     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2022-02-16 4 S $9.05 $8,905 D/D (984) 76,790 -48%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2022-02-16 4 S $9.05 $12,380 D/D (1,368) 47,848 -48%     
   Pitman Jama See Remarks   •       –      –    2022-02-16 4 S $9.05 $10,371 D/D (1,146) 37,959 -48%     
  290 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us